Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the Kidney
Open Access
- 15 June 2022
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2022, 1-11
Abstract
Background. Immune-related long noncoding RNAs (IrlncRNAs) are recognized as important prognostic factors in a variety of cancers, but thus far, their prognostic value in pediatric rhabdoid tumor of the kidney (pRTK) has not been reported. Here, we clarified the associations between IrlncRNAs and overall survival (OS) of pRTK patients and constructed a model to predict their prognosis. Methods. We accessed RNA sequencing data and corresponding clinical data of pRTK from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) database. An expression profile of immune-related genes (Irgenes) and lncRNAs of pRTK was extracted from the RNA sequencing data. IrlncRNAs were defined by co-expression analysis of lncRNAs and Irgenes. The limma R package was used to identify differential expression IrlncRNAs. Univariate and multivariate Cox regression analyses were conducted to build a prognostic IrlncRNAs model. The performance of this prognostic model was validated by multimethods, like ROC curve analysis. Results. A total of 1097 IrlncRNAs were defined. Univariate Cox regression analysis identified 7 IrlncRNAs (AC004791.2, AP003068.23, RP11-54O7.14, RP11-680F8.1, TBC1D3P1-DHX40P1, TUNAR, and XXbac-BPG308K3.5) and were significantly associated with OS. Multivariate regression analysis constructed the best prognostic model based on the expression of AC004791.2, AP003068.23, RP11-54O7.14, TBC1D3P1-DHX40P1, and TUNAR. According to the prognostic model, a risk score of each patient was calculated, and patients were divided into high-risk and low-risk groups accordingly. The survival time of low-risk patients was significantly better than high-risk patients ( ). Univariate (hazard ratio 1.098, 95% confidence interval 1.048–1.149, value value Conclusions. The prognostic model based on 5 IrlncRNAs was robust and could better predict the survival of pRTK than other clinical factors. Additionally, the mechanism of regulation and action of prognosis-associated lncRNAs could provide new avenues for basic research to explore the mechanism of tumor initiation and development in order to prevent and treat pRTK.Keywords
Funding Information
- Guangzhou Municipal Science and Technology Program key projects (201902020001)
This publication has 52 references indexed in Scilit:
- An emerging understanding of long noncoding RNAs in kidney cancerJournal of Cancer Research and Clinical Oncology, 2014
- ImmPort: disseminating data to the public for the future of immunologyImmunologic Research, 2014
- p38β, A Novel Regulatory Target of Pokemon in Hepatic CellsInternational Journal of Molecular Sciences, 2013
- A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapyBiomaterials, 2012
- The functional role of long non-coding RNA in human carcinomasMolecular Cancer, 2011
- Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: A report of the SIOP renal tumour study groupPediatric Blood & Cancer, 2010
- Genome wide expression profiling identifies specific deregulated pathways in meningiomaInternational Journal of Cancer, 2008
- Proteomics of acute myeloid leukaemia: cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modificationsOncogene, 2006
- Rhabdoid Tumor of KidneyAmerican Journal of Surgical Pathology, 1989
- Clinical aspects of the rhabdoid tumor of the kidney: A report of the national wilms' tumor study groupMedical and Pediatric Oncology, 1983